pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
AMGEN · news · pharmadog
← back to AMGEN
News mentioning AMGEN
239
stories
Jun 8, 26
Tango data add to growing momentum for pancreatic cancer drugs
biopharma dive
Jun 5, 26
Study data convince Lundbeck to push new migraine drug forward
biopharma dive
Jun 4, 26
STAT+: Does Revolution Medicines’ pancreatic cancer drug have even greater potential?
stat
May 29, 26
Bristol Myers unveils data for one of its next-gen blood cancer drugs
biopharma dive
May 18, 26
Amgen stands by rare disease drug Tavneos amid Japan liver toxicity report
endpoints
May 18, 26
Høeg fired in latest FDA shakeup; 20 people die after taking Amgen drug
biopharma dive
May 15, 26
Amgen expands crackdown on what it says is misuse of 340B program
endpoints
May 15, 26
Biotech leaders campaign for Pazdur; Takeda to lay off 4,500 workers
biopharma dive
May 12, 26
A year after Vertex’s big launch, pain drug research faces a pivotal moment
biopharma dive
May 8, 26
Lilly, Gilead lead pharma’s M&A boom
biopharma dive
May 7, 26
Amgen adds $300M to Puerto Rico budget; Novartis to exit oral drug factory in Germany
endpoints
May 6, 26
Amgen, AbbVie say IRA negotiations impacted Q1 sales
endpoints
May 6, 26
Cases and Conversations™: Next-Generation Pathology Advances and Considerations for Precision Care in Non–Small Cell Lung Cancer
onclive
May 5, 26
Viridian data lift prospects for thyroid eye disease drug
biopharma dive
May 1, 26
Amgen launches late-stage obesity trial in patients who switch from rival drugs
endpoints
May 1, 26
Amgen files update to Tavneos label as FDA escalates push to withdraw
endpoints
Apr 29, 26
FDA tests out ‘real-time’ clinical trials; AbbVie closes in on a KRAS biotech
biopharma dive
Apr 29, 26
STAT+: A patent win for Pfizer and BridgeBio
stat
Apr 29, 26
STAT+: Pharmalittle: We’re reading about the FDA speeding up trials, a Supreme Court hearing on ‘skinny labels,’ and more
stat
Apr 28, 26
STAT+: FDA launches effort to speed up clinical trials, using AI
stat
Apr 28, 26
FDA debuts plan to collect real-time clinical trial data
endpoints
Apr 28, 26
Opinion: FDA commissioner: ‘Smarter,’ real-time clinical trials could transform drug development
stat
Apr 28, 26
FDA claims Amgen drug data were ‘manipulated’; Erasca slides despite ‘home run’ results
biopharma dive
Apr 28, 26
STAT+: Boehringer’s obesity drug shows 16.6% weight loss; more data needed
stat
Apr 28, 26
FDA claims trial 'manipulation' tainted approval of ChemoCentryx drug
endpoints
Apr 24, 26
Lilly tumbles on Foundayo’s shaky week; FDA to issue vouchers for psychedelics
biopharma dive
Apr 23, 26
David Reese to retire from Amgen
endpoints
Dec 23, 25
Fierce Biotech Layoff Tracker 2026: Milestone shrinks HQ workforce during Cardamyst rollout
fiercebiotech
Dec 22, 25
Fierce Biotech Fundraising Tracker '26: VitriVax scores $87M; Ansa adds $71.5M series C
fiercebiotech
← prev
page 8 of 8
next →